IPC to Lead National Materiovigilance Capacity Building Drive at NIMHANS Bengaluru
核心洞察
The Indian Pharmacopoeia Commission (搜索) (IPC) will spearhead a National Sensitization and Capacity Building Programme on Materiovigilance on July 10, 2026, at NIMHANS Bengaluru.
The initiative aims to strengthen competencies in medical device adverse event reporting, with a focus on AI/ML integration for signal detection and proactive surveillance.
The programme brings together healthcare professionals, regulators, biomedical engineers, and industry stakeholders under the theme "Safeguarding Patients through Robust Medical Device Safety and Vigilance Systems."
In a significant move to bolster India's medical device safety infrastructure, the Indian Pharmacopoeia Commission (搜索) (IPC), through the Materiovigilance Programme of India (MvPI), will lead a National Sensitization and Capacity Building Programme on Materiovigilance System in India on July 10, 2026, at the National Institute of Mental Health and Neurosciences (NIMHANS) in Bengaluru.
The capacity-building initiative seeks to enhance awareness and strengthen competencies in medical device vigilance through expert-led deliberations on recent developments in the MvPI, adverse event reporting systems, regulatory perspectives, digital reporting platforms, and emerging technologies shaping the future of device safety monitoring.
A Critical Public Health Priority
The national-level programme assumes critical importance as India's healthcare ecosystem increasingly relies on sophisticated medical devices for diagnosis, treatment, and patient monitoring. Ensuring the safety, performance, and effective monitoring of these devices has emerged as a key public health priority. The initiative aims to build institutional and professional capacities for identifying, reporting, and managing adverse events associated with medical devices, thereby contributing to safer healthcare delivery across the country.
The programme is being organized by NIMHANS, Bengaluru, and Shri Atal Bihari Vajpayee Medical College and Research Institute (搜索), Bengaluru, in collaboration with IPC, the National Coordination Centre for the MvPI under the Ministry of Health and Family Welfare (MoHFW), Government of India.
Programme Theme and Target Audience
Held under the theme, "Safeguarding Patients through Robust Medical Device Safety and Vigilance Systems," the programme will bring together healthcare professionals, biomedical engineers, pharmacovigilance and materiovigilance experts, researchers, academicians, industry stakeholders, Medical Device Monitoring Centre (MDMC) coordinators, and students from medical, pharmacy, nursing, and biomedical engineering disciplines.
Participants will gain updated insights into the functioning and expansion of MvPI, understand mechanisms for reporting medical device-related adverse events, and learn from real-world safety case studies and regulatory experiences. Demonstrations of the Adverse Drug Reactions Monitoring System (ADRMS) portal and other digital reporting tools will provide practical exposure to contemporary reporting modalities.
AI/ML Integration and Future Directions
A major highlight of the programme will be discussions on the future direction of materiovigilance, including the integration of artificial intelligence (AI) and machine learning (ML) technologies to improve signal detection, risk assessment, and proactive surveillance of medical devices. An expert panel discussion will further facilitate dialogue among healthcare providers, regulators, academia, and industry representatives on strengthening India's medical device safety ecosystem.
Key programme highlights include recent updates in MvPI, medical device safety case studies, reporting modalities and ADRMS portal demonstration, regulatory perspectives on medical device vigilance, future directions in materiovigilance including AI/ML integration, and an expert panel discussion on strengthening patient safety.
Government Commitment to Patient Safety
The initiative reflects the Government of India's continued commitment to fostering a robust vigilance culture and strengthening post-market surveillance mechanisms for medical devices. By encouraging timely reporting, knowledge sharing, and stakeholder collaboration, the programme is expected to contribute significantly to improving patient safety outcomes and advancing the country's healthcare quality standards.
Interested participants have been urged to register before June 30, 2026, and become part of a nationwide effort to build a safer and more responsive medical device surveillance system for India.